GLASDEGIB vs GLIMEPIRIDE: Which Drug Is Safer?
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
GLASDEGIB vs GLIMEPIRIDE: Safety Overview
| Metric | GLASDEGIB | GLIMEPIRIDE |
|---|---|---|
| Total FAERS Reports | 521 | 5,572 |
| Deaths Reported | 196 | 552 |
| Death Rate | 37.6% | 9.9% |
| Hospitalizations | 275 | 2,550 |
| Average Patient Age | 67.4 yrs | 66.6 yrs |
| % Female Patients | 38.6% | 46.4% |
| FDA Approval Date | Nov 21, 2018 | Apr 17, 2013 |
| Manufacturer | Pfizer Laboratories Div Pfizer Inc | A-S Medication Solutions |
| Route | ORAL | ORAL |
| Marketing Status | Prescription | Discontinued |